Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|March 25, 2026
CD39 in the pathogenesis of neuro-Behçet disease: is it an immune regulator marker?Khadija Bahrini, Amani Stiti, Sana Boughariou, et al.
F1000Research|February 11, 2025
Factors influencing osteoradionecrosis progression during hyperbaric oxygen therapy: A case studySameh Mezri, Chaima Zitouni, Khadija Bahrini, et al.
Cytokine|April 7, 2018
Cerebrospinal fluid IL-10 as an early stage discriminative marker between multiple sclerosis and neuro-Behçet diseaseMeriam Belghith, Khadija Bahrini, Mariem Kchaou, et al.
Journal of Immunology Research|May 5, 2023
Immune Cell Response during COVID-19 Infection and following SARS-CoV-2 Vaccination in Patients Admitted to Intensive Care UnitKhadija Bahrini, Nejla Stambouli, Mouna Ben Azaiez, et al.
Journal of Clinical Medicine|August 12, 2022
Increased T-bet/GATA-3 and ROR-γt /Foxp3 Ratios in Cerebrospinal Fluid as Potential Criteria for Definite Neuro-Behçet's DiseaseMeriam Belghith, Olfa Maghrebi, Aroua Cherif, et al.
Frontiers in Genetics|March 15, 2021
Differential Gene Expression Patterns in Blood and Cerebrospinal Fluid of Multiple Sclerosis and Neuro-Behçet DiseaseOlfa Maghrebi, Mariem Hanachi, Khadija Bahrini, et al.
Cytokine|March 11, 2020
Discriminative expression of CD39 and CD73 in Cerebrospinal fluid of patients with Multiple Sclerosis and Neuro-Behçet's diseaseKhadija Bahrini, Meriam Belghith, Olfa Maghrebi, et al.
Military Medicine|October 16, 2024
Prognostic Value of ISS and TRISS Scores in Tunisian Terrorism VictimsKhadija Bahrini, Houcine Horchani, Sana Boughariou, et al.
Journal of Immunological Methods|March 15, 2024
Humoral and cellular response of two different vaccines against SARS-CoV-2 in a group of healthcare workers: An observational studyNejla Stambouli, Khadija Bahrini, Chihebeddine Romdhani, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 20, 2022
COVID-19 prophylaxis with doxycycline and zinc in health care workers: a prospective, randomized, double-blind clinical trialNejla Stambouli, Adel Driss, Faten Gargouri, et al.
Pageof 2